Untangling the Web of Polypharmacy: Long-Term Care Needs Action Before Burden Turns Into Harm

Key Takeaways

• Average of seven meds per resident in 2024 study of 67,531 patients
• 67.2% of real‑time alerts suggest lower‑cost alternatives
• Choosing cheaper alternatives lifts fill rates 15% and saves $27.77 monthly
• Deprescribing stalls due to workflow gaps, not clinician awareness
• Integrated cost‑alert tech improves provider‑approved medication changes

Pulse Analysis

Polypharmacy has become a defining challenge for the aging long‑term care sector. As seniors accumulate chronic conditions—cardiovascular disease, diabetes, dementia, and pain—clinicians often prescribe five or more drugs to manage each ailment. The 2024 cross‑sectional analysis of more than 67,000 facility‑based patients revealed an average of seven medications per resident, with a high incidence of potentially inappropriate prescriptions. Age‑related physiological changes further amplify the risk of drug‑drug interactions, falls, and cognitive decline, turning a well‑intentioned regimen into a safety liability. Consequently, facilities face higher staffing demands to monitor drug interactions and manage adverse events.

Cost considerations are equally pivotal. A recent American Journal of Health‑System Pharmacy study found that 67.2 % of real‑time prescription benefit alerts recommended cheaper alternatives, yet prescribers accepted only a third of them. When a lower‑cost option was chosen, medication fill rates climbed 15 % and patients saved roughly $27.77 per month on copays. These savings are significant for residents on fixed incomes and can reduce the administrative load on facilities that otherwise grapple with missed doses and medication waste. Moreover, lower out‑of‑pocket costs encourage patients to adhere to essential therapies, reducing rehospitalizations.

Technology that embeds cost alerts, duplication checks, and deprescribing cues directly into clinicians’ existing workflows offers a pragmatic solution. By surfacing clinically appropriate alternatives at the point of care, such platforms enable physicians to act swiftly without compromising judgment. Early intervention prevents regimen complexity from spiraling, improves adherence, and lowers adverse event rates. For operators, adopting integrated medication‑management tools translates into measurable quality improvements, regulatory compliance, and a stronger value proposition for families seeking safe, affordable long‑term care. Policymakers are also encouraging reimbursement models that reward deprescribing initiatives, further incentivizing adoption of such technologies.